Association between use of antihypertensives and cognitive decline in the elderly-A retrospective observational study

Prabhpaul Dhami1, Kannayiram Alagiakrishnan2, Ambikaipakan Senthilselvan3

  • 1Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Plos One
|December 20, 2023
PubMed
Abstract

Insights

Beta-blocker use may protect against dementia. This study found beta-blockers were associated with a reduced risk of mild cognitive impairment progressing to dementia in older adults.

Area of Science:

  • Neurology
  • Gerontology
  • Pharmacology

Background:

  • Mild cognitive impairment (MCI) is a precursor to dementia, representing a critical stage for intervention.
  • Understanding factors influencing MCI progression is vital for dementia prevention strategies.

Purpose of the Study:

  • To investigate the association between specific antihypertensive medications and the conversion of MCI to dementia.
  • To identify potential protective effects of certain drug classes in the context of cognitive decline.

Main Methods:

  • Retrospective chart review of 335 older adults diagnosed with MCI at the University of Alberta Hospital.
  • Data collection included demographics, cognitive function, blood pressure, antihypertensive use, and risk factors.
  • Logistic regression analysis was used to determine factors associated with MCI to dementia conversion over a 5.5-year follow-up period.

Main Results:

  • Patients converting to dementia were older and had a higher likelihood of a family history of dementia.
  • After adjusting for confounders, beta-blocker (BB) use was associated with a 57% reduction in the odds of converting from MCI to dementia (OR: 0.43, 95% CI: 0.23, 0.81).

Conclusions:

  • Beta-blocker use demonstrated a protective effect against the progression from mild cognitive impairment to dementia.
  • Further research is warranted to validate these findings and explore the mechanisms underlying the effect of beta-blockers on cognitive decline.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
114
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
54